FDA device listing

Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

FDA device listing 1373971836 · CEPHEID

Key facts

Owner/operator CEPHEID
Owner/operator number 9062742
Premarket submissions K242071
Product codes QOF
Device names QOF - Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents
Device class Class II
Classification regulations (21 CFR) 866.3981
Review panels Microbiology
Registered establishments Cepheid, CEPHEID, CEPHEID AB
Establishment registrations 3004530258, 3009613136, 3016838963
FEI numbers 3004530258, 3009613136, 3016838963
Establishment operations Contract Manufacturer, Manufacturer, Specification Developer
Registration valid through 2026

At a glance

  • 1–9 Registered establishments listing this device
  • 1–9 UDI devices (GUDID) under the same submission
  • 1–9 Device listings citing the same submission
  • Yes Premarket submission listed

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA device listings

Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.

Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database

Browse all FDA device listings